Skip to content

Medical-device intelligence

OIW: Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

FDA product code OIW: Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
OIW
FDA device name
Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types
Device class
2
Regulation number
862.3100
Medical specialty
Clinical Toxicology
Review panel
TX

FDA definition

This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.
Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 0 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Jul 30, 2008 to Mar 15, 2018.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
Tissue of Origin Test Kit-FFPEK173839 · OIWCancer Genetics, Inc.510(k)Mar 15, 2018FDA decision date
TISSUE OF ORIGIN TEST KIT FFPEK120489 · OIWPathwork Diagnostics, Inc.510(k)May 17, 2012FDA decision date
PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPEK092967 · OIWPathwork Diagnostics510(k)Jun 8, 2010FDA decision date
PATHWORK DIAGNOSTICS TISSUE OF ORIGIN TESTK080896 · OIWPathwork Diagnostics, Inc.510(k)Jul 30, 2008FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗